Navigation Links
Lilly Diabetes Announces Once Upon A Time Contest Winner
Date:7/2/2012

INDIANAPOLIS, July 2, 2012 /PRNewswire/ --

News Highlights

  • Lilly #Diabetes sending winning family to #FFL12
  • Once Upon A Time Contest celebrates life with type 1 #diabetes #FFL12
  • Family wins trip to annual #FFL12 from Lilly #Diabetes Once Upon A Time Contest

Lilly Diabetes today announced Meri Schuhmacher as the winner of its Once Upon A Time Contest. Lilly Diabetes created the Contest to spark a national dialogue about type 1 diabetes by asking family members to write about their experience with diabetes. The Contest launched at the same time Lilly Diabetes and Disney announced a new collaboration to combine Lilly's deep understanding of diabetes with Disney magic to provide inspiration, education and practical advice for caregivers and people with type 1 diabetes.

"Winning this contest means so much to my family," said Meri Schuhmacher. "Living with type 1 diabetes can be challenging, but also inspiring. The Once Upon A Time Contest reminds us to celebrate our lives with diabetes, and the Friends for Life annual meeting is the ultimate way to do that while we connect with other families with similar experiences.  We can't wait to attend!"

Schuhmacher's winning entry shared her story as the mother of four boys, three of whom are living with type 1 diabetes. Her inspiring essay is featured on Disney Family.com's type 1 diabetes website, www.family.com/type1. The Schuhmacher family lives in Petaluma, CA.

Launched in July 2011, the Once Upon A Time Contest encouraged parents and caregivers to submit an original written work inspired by their child's experience with type 1 diabetes. The winning entry was determined by a panel of independent judges. The Schuhmachers were awarded a five-day/four-night trip to the 2012 children with DIABETES annual conference, Friends for Life, in Orlando, FL, from July 3-8, 2012.

About Lilly Diabetes

Lilly has been a global leader in diabetes care since 1923, when we introduced the world's first commercial insulin. Today we work to meet the diverse needs of people with diabetes through research and collaboration, a broad and growing product portfolio and a continued commitment to providing real solutions—from medicines to support programs and more—to make lives better. For more information, visit www.lillydiabetes.com.

About Eli Lilly and Company (NYSE: LLY)

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, IN, Lilly provides answers—through medicines and information—for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.  C-LLY

(Logo: http://photos.prnewswire.com/prnh/20111111/DE03493LOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Lilly Statement on Affordable Care Act Ruling by Supreme Court
2. Lilly Statement on PDUFA Vote by Senate
3. PrimeraDx Announces Commencement of Product Development Collaboration with Eli Lilly and Company
4. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
5. Lilly Diabetes Launches 8th Annual Diabetes Summer Camp Tour With Olympian Kris Freeman
6. Lilly Expands Strategic Partnership with Chinese Manufacturer Novast to Serve Chinese Patients with High-Quality Branded Generic Medicines
7. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
8. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
9. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
10. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
11. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/7/2017)... , Oct. 6, 2017   Provista, a ... than $100 billion in purchasing power, today announced a ... information. The Newsroom is the online home ... trends, infographics, expert bios, news releases, slideshows and events. ... to a wealth of resources at their fingertips, viewers ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... Women-owned and Grand Rapids-based workplace ... Brightest in Wellness® by Best and Brightest. OnSite Wellness will be honored at ... from 7:30 a.m. to 2 p.m. at the Henry Autograph Collection Hotel, located ...
Breaking Medicine News(10 mins):